IESE (España)
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Caja Navarra: Reporting Customer Profitability... to Customers
Davila, Antonio; Aranda, C.; Arellano, J.Case C-747-EAccounting and ControlThe case can be used to teach customer profitability analysis in a service firm (bank). The case describes the decision of a bank (CAN) to disclose customer profitability to its customers. It describes how customer profitability is estimated and alternatives to this approach to estimating it. It also describes the bank's strategy that led to its decision to report to customers how much the bank makes on each one of them.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Caja Navarra: rentabilidad de cliente... para el cliente
Davila, Antonio; Aranda, C.; Arellano, J.Case C-747Accounting and ControlEste caso se puede emplear para enseñar sobre el análisis de rentabilidad del cliente en una empresa de servicios (banco). Describe la decisión de un banco (CAN) de divulgar la rentabilidad de cliente a cada uno de sus clientes además de cómo se realiza la estimación de dicha rentabilidad y los enfoques alternativos a esa valoración, así como la estrategia que condujo a la caja a tomar la decisión de informar a los clientes sobre cuánto ganaba co...Starting at €8.20